Mild intermittent asthma with (acute) exacerbation
Methodology & AI Transparency ⓘ
Mild intermittent asthma with (acute) exacerbation Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Physicians managing Mild intermittent asthma with (acute) exacerbation (J45.21; Asthma, COPD & Respiratory Disease) utilize high-resolution chest imaging in Mild intermittent asthma with (acute) exacerbation (J45.21: when indicated) and objective Resting Pulse Oximetry in Mild intermittent asthma with (acute) exacerbation (J45.21: (SpO2)) targets (96% – 100% (J45.21)) to prevent progression and functional morbidity.
- 2 Real-world patient consensus: Mapped to Asthma, COPD & Respiratory Disease under ICD-10-CM J45.21 for Mild intermittent asthma with (acute) exacerbation clinical workups.
- 3 Typical cash cost range: Differential triage of Mild intermittent asthma with (acute) exacerbation (J45.21) utilizes high-resolution chest imaging in Mild intermittent asthma with (acute) exacerbation (J45.21: when indicated).
- 4 Top reported side effects / signs: Longitudinal Mild intermittent asthma with (acute) exacerbation monitoring tracks Resting Pulse Oximetry in Mild intermittent asthma with (acute) exacerbation (J45.21: (SpO2)) toward 96% – 100% (J45.21).
Ask our AI Specialists anything about Mild intermittent asthma with (acute) exacerbation
What Is Mild intermittent asthma with (acute) exacerbation?
Physicians managing Mild intermittent asthma with (acute) exacerbation (J45.21; Asthma, COPD & Respiratory Disease) utilize high-resolution chest imaging in Mild intermittent asthma with (acute) exacerbation (J45.21: when indicated) and objective Resting Pulse Oximetry in Mild intermittent asthma with (acute) exacerbation (J45.21: (SpO2)) targets (96% – 100% (J45.21)) to prevent progression and functional morbidity.
Pathophysiology, Underlying Causes & Clinical Presentation
In Mild intermittent asthma with (acute) exacerbation (J45.21), physiological disruption stems from bronchial smooth-muscle hyperresponsiveness [Mild intermittent asthma with (acute) exacerbation J45.21], informing Asthma, COPD & Respiratory Disease protocols that track Blood Eosinophil Count [Mild intermittent asthma with (acute) exacerbation J45.21] (< 150 cells/uL (phenotyping marker) (J45.21)).
Common Symptoms & Clinical Signs
- • Presentation of Mild intermittent asthma with (acute) exacerbation (J45.21): prolonged recovery from in Mild intermittent asthma with (acute) exacerbation (J45.21: viral respiratory infections)
- • Secondary Mild intermittent asthma with (acute) exacerbation clinical sign: declining stair-climbing stamina in Mild intermittent asthma with (acute) exacerbation (J45.21: or frequent rescue)
- • Symptom flares in Mild intermittent asthma with (acute) exacerbation correlating with Resting Pulse Oximetry in Mild intermittent asthma with (acute) exacerbation (J45.21: (SpO2)) deviation outside 96% – 100% (J45.21)
- • Functional lungs & asthma impact requiring high-resolution chest imaging in Mild intermittent asthma with (acute) exacerbation (J45.21: when indicated) evaluation (J45.21)
Mild intermittent asthma with (acute) exacerbation Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | J45.21 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Asthma, COPD & Respiratory Disease | NLM Clinical Tables |
| Diagnostic / Lab Marker: Resting Pulse Oximetry in Mild intermittent asthma with (acute) exacerbation (J45.21: (SpO2)) | 96% – 100% (J45.21) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Blood Eosinophil Count [Mild intermittent asthma with (acute) exacerbation J45.21] | < 150 cells/uL (phenotyping marker) (J45.21) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Spirometry FEV1 / in Mild intermittent asthma with (acute) exacerbation (J45.21: FVC Ratio) | >= 0.75 (FEV1 >= 80% predicted) (J45.21) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Mild intermittent asthma with (acute) exacerbation
Treatment selection for Mild intermittent asthma with (acute) exacerbation depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Mild intermittent asthma with (acute) exacerbation)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| GLP-1RA vs. Placebo: Which Works Better for Heart failure and mildly reduced or preserved ejection fraction? GLP-1RA reduce HF exacerbations and can play a role in reducing hospitalizations, improving patient's functional status, and significantly impacting the global healthcare burden of HF. International journal of cardiology • 2025-11-01 • Meta-Analysis | N = 4,474 | 99/100 | PMID 40623630 ↗ |
| New Insights on Skin-applied tazarotene in the treatment of mild to moderate: What a 468-Participant Study Found In general, 'using the cream formulation rather than the gel formulation optimized tolerability. Cutis • 2004-10-15 • Meta-Analysis | N = 468 | 97/100 | PMID 15543714 ↗ |
| New Insights on Mineralocorticoid Receptor Antagonism with Finerenone: A New Era in the: What a 13,026-Participant Study Found We explore the emerging role of the nonsteroidal MRA finerenone as a new therapeutic opportunity to improve the risk of adverse heart and blood vessel outcomes in patients with HF and mildly reduced or preserved ejection. American journal of cardiovascular drugs : drugs, devices, and other interventions • 2025-07-15 • Phase III Randomized Trial | N = 13,026 | 96/100 | PMID 40055303 ↗ |
| New Insights on Efficacy of finerenone in patients with heart failure and mildly reduced or: What a 3,497-Participant Study Found Among patients with HFpEF/HFmrEF in FINEARTS-HF, higher baseline HR was associated with a higher risk of the primary outcome in patients with SR but not in those with AF. European journal of heart failure • 2026-05-02 • Phase III Randomized Trial | N = 3,497 | 96/100 | PMID 41771075 ↗ |
| Check Your Medicine Cabinet: Family Farmstead Dairy Announces Recall of Raw Mild Cheddar Cheese Due to Potential E. c WORCESTER, NY, October 15, 2026 - Family Farmstead Dairy of Worcester, NY is recalling specific lot of cheddar cheese because it may be contaminated with Escherichia coli O157:H7 bacteria (E. Coli O157:H7). E. coli O157:H7 causes a diarrheal illness often with FDA Drug Recalls • 2026-10-15 • FDA Recall | Multi-cohort | 95/100 | PMID FDA_RECALLS-2412744266 ↗ |
Mild intermittent asthma with (acute) exacerbation Patient Community & “People Like Me” Threads
Filter Mild intermittent asthma with (acute) exacerbation community threads and patient logs by age, biological sex, dosage, and treatment duration.